BP : UBS to buy pending annual results
The broker sees this meeting as a 'chance to improve the narrative', mentioning also a possible downward revision of capital expenditure, and an inexpensive valuation with upside potential for 2025 estimates.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction